Indication
Prevention of transient ischemic attack
Prevention of transient ischemic attack refers to therapeutic interventions designed to avert brief episodes of temporary focal neurological dysfunction in individuals at high risk for cerebrovascular events. Read more about Prevention of transient ischemic attack
249 drugs 129 manufacturers
Drugs that treat it
Common Prevention of transient ischemic attack therapies.
SIMVASTATIN
LOW DOSE ASPIRIN EC (aspirin)
ROSUVASTATIN CALCIUM
SIMVASTATIN
PRAVASTATIN SODIUM
SIMVASTATIN
ASPIRIN EC (aspirin)
PRAVASTATIN SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of transient ischemic attack refers to therapeutic interventions designed to avert brief episodes of temporary focal neurological dysfunction in individuals at high risk for cerebrovascular events.
These episodes arise from acute, localized hypoperfusion in the central nervous system—predominantly affecting the brain, spinal cord, or retina—caused by transient microemboli, large-artery atherosclerosis, or cardiac thromboembolism.
Clinically defined by reversible neurological deficits, such as unilateral motor weakness, sensory changes, or language impairment that resolve without evidence of acute infarction on neuroimaging, prevention targets the vascular system to halt progressive cerebral ischemia and diminish the substantial risk of subsequent recurrent ischemia or completed ischemic stroke.
- nih.gov
Prevention of transient ischemic attack refers to therapeutic interventions designed to avert brief episodes of temporary focal neurological dysfunction in individuals at high risk for cerebrovascular events Clinically defined by reversible neurological deficits, such as unilateral motor weakness, sensory changes, or language impairment that resolve without evidence of acute infarction on neuroimaging, prevention targets the vascular system to halt progressive cerebral ischemia and diminish the ...
- nih.gov
Prevention of transient ischemic attack refers to therapeutic interventions designed to avert brief episodes of temporary focal neurological dysfunction in individuals at high risk for cerebrovascular events These episodes arise from acute, localized hypoperfusion in the central nervous system—predominantly affecting the brain, spinal cord, or retina—caused by transient microemboli, large-artery atherosclerosis, or cardiac thromboembolism Clinically defined by reversible neurological deficits, s...
- nih.gov
These episodes arise from acute, localized hypoperfusion in the central nervous system—predominantly affecting the brain, spinal cord, or retina—caused by transient microemboli, large-artery atherosclerosis, or cardiac thromboembolism
Personalize your experience
Follow Prevention of transient ischemic attack and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.